Buscar
Mostrando ítems 31-40 de 76
Development of COVID-19 monoclonal antibodies and recombinant proteins as reagents for biomedical research and diagnostic test
(Sociedad Argentina de Bioquímica y Biología Molecular, 2021)
Since SARS-COV-2 virus spread worldwide and COVID-19 turned rapidly into a pandemic illness, the necessity for vaccines and diagnostic tests became crucial. The viral surface is decorated with Spike, the major antigenic ...
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
(Springer Nature, 2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebocontrolled, phase 2 trial
Background This is the first randomised controlled trial for assessment of the immunogenicity and safety of a
candidate non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine, aiming to determine an appropriate
dose ...
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
In December of 2019, an outbreak of inexplicable pneumonia cases
in several patients appeared in Wuhan, China. What is now known as
coronavirus disease 2019 (COVID-19) has spread widely since then and,
as of this writing, ...
Development of highly stable and de-immunized versions of recombinant alpha interferon: promising candidates for the treatment of chronic and emerging viral diseases
(Elsevier, 2021-12)
Human interferon alpha (hIFN-α) administration constitutes the current FDA approved therapy for chronic Hepatitis B and C virus infections. Additionally, hIFN-α treatment efficacy was recently demonstrated in patients with ...
Vacuna contra COVID-19 y administración de otras vacunas
(Universidad Nacional de Córdoba, Facultad de Ciencias Químicas. Centro de Información de Medicamentos., 2021-03-26)
Este Informe, destinado a profesionales de la salud, se ha elaborado en base a las preguntas frecuentes recibidas en el CIME, sobre la administración de vacunas contra COVID-19 y otras vacunas.
En Argentina, hasta el 25 ...
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
(Massachusetts Medical Society, 2021)
Worldwide Overview of the Different COVID-19 Vaccine Platforms:A Review and Reflection on the Current EvidencePanorama mundial de las diferentes plataformas de vacunas contra el COVID-19: revisión y reflexión de la literatura actual
(Revista Científica Salud Uninorte, 2022)
Vaccines are biological products containing antigens that aim to generate protection against real exposure to an infectious pathogen. They constitute the most cost-effective interven-tions in public health, being surpassed ...
SARS-CoV-2 vaccines: evolution and escapeVacunas SARS-CoV-2: evolución y escape
(Universidad de Córdoba, 2021)
Vacunas SARS CoV-2, estudios en fase III
(Soc. Chilena Infectología, 2021)
La enfermedad por coronavirus 2019, causada por el virus SARSCoV2,
fue declarada pandemia en marzo de 2020 por la OMS. La
proteína S, de la superficie viral ha sido identificada como antígeno
óptimo para el desarrollo ...